Article
Launching “At Risk” In The UK: Why Recent Patent Injunction Decisions Matter For MedTech And Digital Health Companies
Launching a product while a patent dispute remains unresolved has never been risk‑free, but many companies have taken the view that the commercial upside justified it.

Marks & Clerk
